Chief Executive Officer
Chris Grimes is a commercial manager and has a wealth of experience within the pharmaceutical industry. Chris gained vast experience managing and launching pharmaceutical products within global markets and delivering technology transfer projects on multiple product ranges. Previously Chris has worked for UCB Pharma Ltd within their Commercial Business, becoming Business Unit Manager of the Global Minijet Franchise. Chris now provides commercial oversight and strategic guidance to support the future growth of Veriton Pharma.
Dr. Hannah Aiken
Chief Scientific Officer
Dr Hannah Aiken joined Veriton Pharma in 2013 as a highly skilled pharmaceutical product development expert. After completing her PhD at Kings College London, Hannah joined MedPharm where she gained extensive product development and analytical experience through the development of a variety of dosage forms. Hannah has developed projects at all stages, from proof of concept through to robust commercial products, including products which have subsequently been awarded a Marketing Authorisation. Hannah is listed as an inventor on a number of patents and has published numerous papers. At Veriton Pharma, Hannah was promoted to Head of Product Development and Medical Services in 2017 and then most recently to Chief Scientific Officer in 2018.
General Manager MEA
Emeel has 20 years of global Sales & Marketing medical and pharmaceutical experiences at senior level with strong strategic and commercial orientation with strengths in leadership, team building, business development and launching new products.
Emeel has gained his experience through working at major healthcare companies such as Novartis, Johnson and Johnson Medical.
Emeel Joined Veriton Pharma in 2011 in the role of Regional Sales Manager before being promoted to be General Manager Middle East and Africa based in Dubai.